Small Cell Lung Cancer News and Research

RSS

Small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung. Small cell lung cancer is an aggressive (fast-growing) cancer that can spread to other parts of the body. The cancer cells look small and oval-shaped when looked at under a microscope.

Biomarker blood test detects recurrences of lung cancer before conventional imaging methods

Results from a prospective clinical trial showed that a blood test looking at specific biomarkers was able to detect recurrences of lung cancer an average of six months before conventional imaging methods found evidence of recurrence.

17 Mar 2017

Intensity modulated proton therapy shows early promise for treatment of recurrent lung cancer

An advanced form of image-guided radiation therapy, known as intensity modulated proton therapy, has shown early promise for the treatment of recurrent lung cancer, according to new research from The University of Texas MD Anderson Cancer Center.

17 Mar 2017

Roswell Park-led study shows benefits of ‘one and done’ SBRT treatment approach for NSCLC patients

New research led by a radiation oncologist at Roswell Park Cancer Institute indicates that less may be more when it comes to some forms of radiation therapy for cancer.

17 Mar 2017

UT Southwestern researchers develop computer model to predict most deadly lung cancers

After evaluating more than 900 differences in the shape and structure of cancer cells, UT Southwestern Medical Center researchers developed a computer model able to predict the most deadly lung cancers based on a fraction of those features.

16 Mar 2017

Penn studies provide new understanding of lung cancer progression and prevention

Treating the brain with a preventative course of radiation may help Small Cell Lung Cancer (SCLC) patients - whose tumors often spread to their brain -- live longer, according to a new study from researchers in the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania.

16 Mar 2017

Study shows decreased incidence of radiation esophagitis in elderly NSCLC patients

Elderly non-small cell lung cancer (NSCLC) patients undergoing definitive radiation have a lower incidence of esophagitis compared to younger patients and tolerate aggressive standard treatment regimens.

1 Feb 2017

ALCMI and Scancell collaborate to advance cancer vaccine clinical trials in NSCLC patients

The Addario Lung Cancer Medical Institute, the Bonnie J. Addario Lung Cancer Foundation and Scancell Holdings PLC today announce a collaboration to evaluate the use of Scancell's second innovative cancer vaccine, SCIB2, from its ImmunoBody platform to treat non-small cell lung cancer.

30 Jan 2017

Antibodies can activate nerve cells within milliseconds, study shows

Antibodies are able to activate human nerve cells within milliseconds and hence modify their function -- that is the surprising conclusion of a study carried out at Human Biology at the Technical University of Munich.

28 Jan 2017

Lung cancer patients who experience anxiety and depression more likely to die sooner, study reveals

Patients who experience anxiety and depression after being diagnosed with advanced lung cancer are more likely to die sooner, according to new research from the University of British Columbia and BC Cancer Agency.

24 Jan 2017

New drugs that target neighbour proteins may help halt cancer progression

Cancer is caused by an accumulation of genetic changes in a cell, that overcome the normal checks and balances leading to uncontrolled growth. A complex, interacting network of proteins controls all of a cell's processes, from metabolism to growth and division.

24 Jan 2017

Study provides scientific insight into metastatic patterns of EGFR mutated NSCLCs

The discovery of several different subtypes of Non Small Cell Lung Cancer (NSCLC), the most frequent form of lung cancer, has been a major breakthrough in the fight against the leading cause of cancer-related death worldwide.

20 Jan 2017

Overall survival of advanced NSCLC patients receiving treatment better than untreated patients

Non-small cell lung cancer patients with advanced disease receiving standard of care treatment have a higher overall survival than similar patients not receiving treatment.

19 Jan 2017

Cancers acquire resistance to immunotherapy by eliminating tumor-specific genetic mutations

Results of an initial study of tumors from patients with lung cancer or head and neck cancer suggest that the widespread acquired resistance to immunotherapy drugs known as checkpoint inhibitors may be due to the elimination of certain genetic mutations needed to enable the immune system to recognize and attack malignant cells.

6 Jan 2017

Small Cell Lung Cancer News and Research

Biomarker blood test detects recurrences of lung cancer before conventional imaging methods

Intensity modulated proton therapy shows early promise for treatment of recurrent lung cancer

Roswell Park-led study shows benefits of ‘one and done’ SBRT treatment approach for NSCLC patients

UT Southwestern researchers develop computer model to predict most deadly lung cancers

Penn studies provide new understanding of lung cancer progression and prevention

Study shows decreased incidence of radiation esophagitis in elderly NSCLC patients

ALCMI and Scancell collaborate to advance cancer vaccine clinical trials in NSCLC patients

Antibodies can activate nerve cells within milliseconds, study shows

Lung cancer patients who experience anxiety and depression more likely to die sooner, study reveals

New drugs that target neighbour proteins may help halt cancer progression

Study provides scientific insight into metastatic patterns of EGFR mutated NSCLCs

Overall survival of advanced NSCLC patients receiving treatment better than untreated patients

Cancers acquire resistance to immunotherapy by eliminating tumor-specific genetic mutations

Delayed chemotherapy after surgery may benefit lung cancer patients, new Yale study suggests

NSCLC patients treated with surgery may benefit from delayed chemotherapy, study shows

Fred Hutch’s new Evergreen Fund to promote commercialization of research into lifesaving therapies

Study reveals impact of histology on SBRT treatment in early-stage NSCLC patients

Breast cancer patient finds new hope with potentially revolutionary treatment

PD-1 protein could serve as biomarker for predicting survival of lung cancer patients

Cancer experts to discuss novel treatment strategies at ESMO Asia 2016 Congress

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News